KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) EBITDA (2016 - 2025)

Historic EBITDA for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $2.1 billion.

  • Cvs Health's EBITDA fell 1081.08% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.7 billion, marking a year-over-year decrease of 4527.95%. This contributed to the annual value of $4.7 billion for FY2025, which is 4527.95% down from last year.
  • Per Cvs Health's latest filing, its EBITDA stood at $2.1 billion for Q4 2025, which was down 1081.08% from -$3.2 billion recorded in Q3 2025.
  • Cvs Health's EBITDA's 5-year high stood at $4.7 billion during Q2 2022, with a 5-year trough of -$3.9 billion in Q3 2022.
  • Moreover, its 5-year median value for EBITDA was $3.1 billion (2021), whereas its average is $2.4 billion.
  • Per our database at Business Quant, Cvs Health's EBITDA skyrocketed by 19415.67% in 2023 and then tumbled by 48545.67% in 2025.
  • Quarter analysis of 5 years shows Cvs Health's EBITDA stood at $2.3 billion in 2021, then surged by 55.97% to $3.7 billion in 2022, then decreased by 7.82% to $3.4 billion in 2023, then decreased by 29.8% to $2.4 billion in 2024, then fell by 10.81% to $2.1 billion in 2025.
  • Its EBITDA stands at $2.1 billion for Q4 2025, versus -$3.2 billion for Q3 2025 and $2.4 billion for Q2 2025.